Tag:

Cardio3 BioSciences

Latest Headlines

Cardio3 garners $17.7M for heart muscle therapy

January 20, 2009

Belgian biotech Cardio3 BioSciences has rounded up €13.7 million from venture groups and grants. Cardio3 raised €7.2 million in a Series B and an additional €6.5 million in cash

THE LIBRARY: WEBINAR

Getting the most PoC data in Phase I cancer studies

| June 12, 11am ET/ 8am PT

The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!

MORE ITEMS

EVENTS

MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
What's your BIO?June 18-21, 2012 — Boston, MA

MORE EVENTS

Press Releases

Featured Jobs

Entry Level Process Engineer and Lead Process Engineer
Foster Wheeler Biokinetics - San Francisco, CA
Sr. IT Infrastructure Architect Job
Celgene Corporation - Berkeley Heights, NJ, US
Director, Clinical Safety
Daiichi Sankyo - Edison, NJ
Statistician Job
Yoh - Montville, NJ, USA
Quality Assurance Specialist Job
Yoh - Lexington, MA, USA

Cardio3 BioSciences

Latest Headlines

Latest Headlines

Cardio3 garners $17.7M for heart muscle therapy

THE LIBRARY: WEBINAR

EVENTS

Press Releases

Featured Jobs

A publication of FierceMarkets

The FierceMarkets Network:

Telecom

Healthcare

Government

Energy

Life Sciences

Enterprise IT

Finance

Cardio3 BioSciences

Latest Headlines

Latest Headlines

Cardio3 garners $17.7M for heart muscle therapy

Related Tags